Paradigm Biocapital Advisors LP NUVL Holdings History
Paradigm Biocapital Advisors LP's Nuvalent Inc Holding Summary
As of 2025-03-31, Paradigm Biocapital Advisors LP held 5.27 Mil shares of Nuvalent Inc(NUVL), totaling $373.71 Mil. This investment constitutes 17.12% of their stock portfolio, and Paradigm Biocapital Advisors LP now holds 7.34% of the outstanding Nuvalent Inc(NUVL) stock.
The initial trade took place in 2023Q2. And since then Paradigm Biocapital Advisors LP has made 7 purchases of NUVL, at an average price of $60.67, for a total of 5.36 Mil shares. In addition, there have been 1 sales at an average price of $78.19 for 93,946.00 shares. Based on historical transaction data and NUVL's current price of $83.87, Paradigm Biocapital Advisors LP's estimated gain on his NUVL holdings is $123.92 Mil, reflecting a 38.08% gain to date.
Paradigm Biocapital Advisors LP NUVL ($83.87) Holding Chart
Paradigm Biocapital Advisors LP NUVL ($83.87) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
